1 Rungta Institute of pharmaceutical Sciences and Research, Kohka, Kurud, Bhilai,490024, Chhattisgarh.
2 Rungta Institute of Pharmaceutical Sciences, Kohka, Kurud, Bhilai,490024, Chhattisgarh.
World Journal of Biology Pharmacy and Health Sciences, 2025, 23(02), 223–231
Article DOI: 10.30574/wjbphs.2025.23.2.0753
Received on 27 June 2025; revised on 11 August 2025; accepted on 13 August 2025
Mycoses, another name for fungal infections, are caused by pathogenic fungi that can infect many regions of the human body. These infections can be classified as superficial, cutaneous, subcutaneous, or systemic; systemic infections can result in serious and potentially fatal diseases. Human infections are frequently caused by fungi, including dermatophytes, Aspergillus, Candida, and Cryptococcus. Immunocompromised conditions (e.g., HIV/AIDS, organ transplantation, chemotherapy), diabetes, and long-term use of corticosteroids or broad-spectrum antibiotics are risk factors for fungal infections. Depending on the species of fungus and the infection site, the clinical symptoms can range from minor skin diseases to serious, widespread infections that impact internal organs such as the heart, brain, and lungs. Molecular methods, microbiological cultures, and clinical examination are commonly used in diagnosis. Among the available treatments are antifungal.
Fungal Infection; Clotrimazole; Allylamine; Mycoses
Preview Article PDF
Bhumika Chandrakar, Naveen Kumar Sahu, Jyoti Prakash, Rukhmani Raman Sahu, Hariom Rajput and Gyanesh Kumar Sahu. A review on clotrimazole in the treatment of fungal infection. World Journal of Biology Pharmacy and Health Sciences, 2025, 23(02), 223-231. Article DOI: https://doi.org/10.30574/wjbphs.2025.23.2.0753.